Adjunctive hyperbaric oxygen therapy in the treatment of rhinocerebral mucormycosis

Infections in Medicine

Volumn 13, Issue 2, 1996, Pages 130-136

  Giitter, Michael F ^a   Henderson, Loire T ^b   Afsari, Khosrow K ^b,d   Serebrakian, Armen A ^b,d   Alway, Clair ^c   Cianci, Paul ^b,d  

^a United States Navy   (United States)

^b Brookside Hospital   (United States)

^c Hyperbaric Oxygen/Wound Care Center   (United States)

^d Brookside Hospital   (United States)

Author keywords

amphotericin B; hyperbaric oxygen; infection, central nervous system; infection, fungal; mucormycosis

Indexed keywords

AMPHOTERICIN B;

ADULT; AGED; ARTICLE; CASE REPORT; DEBRIDEMENT; FEMALE; HUMAN; HYPERBARIC OXYGEN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MUCORMYCOSIS; PRESCHOOL CHILD; RHINOCEREBRAL MUCORMYCOSIS;

EID: 0029871754     PISSN: 07496524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Sugar AM: Agents of mucormycosis and related species, in Mandell GL, Douglas RG, Bennett JE (eds): Principles and Practice of Infectious Diseases and Their Etiologic Agents, ed 3. New York: Churchill Livingstone, 1990, pp 1962-1972.
2. Couch L, Theilen F, Mader JT: Rhinocerebral mucormycosis with cerebral extension successfully treated with adjunctive hyperbaric oxygen therapy. Arch Otolaryngol Head Neck Surg 114:791-794, 1988.
3. Mangilia A, Minz D, Novaks S: Cephalic phycomycosis: A report of 80 patients. Laryngoscope 92:755-760, 1982.
4. Bergstrom L, Hemingway WG, Barnhart RA: Rhinocerebral and otological mucormycosis. Ann Otolaryngol Rhinol 79:70-81, 1970.
5. Adam RD, Hunter G, DiTomasso J, et al: Mucormycosis: Emerging prominence of cutaneous infections. Clin Infect Dis 19:67-76, 1994.
6. Ferguson BJ, Mitchell TG, Moon R, et al: Adjunctive hyperbaric oxygen for treatment of rhinocerebral mucormycosis. Rev Infect Dis 10:551-559, 1988.
7. Parfrey NA: Improved diagnosis and prognosis of mucormycosis: A clinicopathologic study of 33 cases. Medicine 65:113-123, 1986.